In addition, the activation of PI3K/Akt/mechanistic target of rapamycin (mTOR) pathway has become a marker of the occurrence of many cancers, and in NSCLC, the PI3K/Akt/mTOR pathway is closely related to tumorigenesis and disease progression (Tan, 2020). This evidence concerns the gene MTOR and non-small cell lung carcinoma.